Diabetologia

Διαβήτης – Ενημερώσεις, Ιανουάριος 2025

από

Το άρθρο απευθύνεται μόνο σε επαγγελματίες υγείας

  • Ελληνική Διαβητολογική Εταιρεία (ΕΔΕ website): Δωρεάν μετεκπαιδευτικά webinars για ιατρούς – “22ος Ετήσιος Κύκλος Διαδικτυακών Σεμιναρίων για τον Σακχαρώδη Διαβήτη” – πρόγραμμα 2025 ➥
  • 19ο Πανελλήνιο Ιατρικό Συνέδριο Παχυσαρκίας από την Ελληνική Ιατρική Εταιρεία Παχυσαρκίας (ΕΙΕΠ website), 6 – 8 Μαρτίου 2025, Ξενοδοχείο Royal Olympic, Αθήνα – ανακοίνωση ➥
  • Rubino, Francesco et al. Definition and diagnostic criteria of clinical obesity, The Lancet Diabetes & Endocrinology, Volume 0, Issue 0, Online first January 14, 2025, DOI: 10.1016/S2213-8587(24)00316-4 ➥ Open Access
     Executive summary: Current BMI-based measures of obesity can both underestimate and overestimate adiposity and provide inadequate information about health at the individual level, which undermines medically-sound approaches to health care and policy. This Commission sought to define clinical obesity as a condition of illness that, akin to the notion of chronic disease in other medical specialties, directly results from the effect of excess adiposity on the function of organs and tissues. The specific aim of the Commission was to establish objective criteria for disease diagnosis, aiding clinical decision making and prioritisation of therapeutic interventions and public health strategies. To this end, a group of 58 experts—representing multiple medical specialties and countries—discussed available evidence and participated in a consensus development process. Among these commissioners were people with lived experience of obesity to ensure consideration of patients’ perspectives. The Commission defines obesity as a condition characterised by excess adiposity, with or without abnormal distribution or function of adipose tissue, and with causes that are multifactorial and still incompletely understood. We define clinical obesity as a chronic, systemic illness characterised by alterations in the function of tissues, organs, the entire individual, or a combination thereof, due to excess adiposity. Clinical obesity can lead to severe end-organ damage, causing life-altering and potentially life-threatening complications (eg, heart attack, stroke, and renal failure)… more ➥ | 24/01/2025 EASO response ➥

  • Moser, O., Zaharieva, D.P., Adolfsson, P. et al. The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) – Diabetologia 68, 255–280 (2025). https://doi.org/10.1007/s00125-024-06308-z ➥ Open Access

Abstract: Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology… more ➥

AID Exercise